|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02157 LEPU BIO
Nominal 
4.235 +0.150 (+3.672%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 522,414 | 12.120% | 934,869 | 367,794 | 225,352 | 15,572 |
| Cost of Sales | (47,037) | 71.649% | (89,591) | (74,824) | (28,277) | (2,005) |
| Gross Profit | 475,377 | 8.400% | 845,278 | 292,970 | 197,075 | 13,567 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 10,623 | -- | (31,249) | 5,077 | 174,976 | (62,816) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 57 | -- | (7,513) | (16,439) | (27,341) | (32,231) | |
| Profit / (Loss) before Taxation | 24,778 | -15.439% | 260,636 | (424,193) | (30,301) | (699,441) | |
| Taxation | 70 | -- | (1,750) | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,545 | -79.547% | 2,478 | 12,817 | 8,205 | 10,389 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 27,393 | -34.380% | 261,364 | (411,376) | (22,096) | (689,052) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 16,662 | 123.801% | 16,981 | 16,989 | 7,756 | (37,272) |
| Depreciation & Amortisation | 51,566 | 9.282% | 93,726 | 100,179 | 102,572 | 95,446 |
| Directors' Emoluments | -- | -- | 4,224 | 3,930 | 15,291 | 18,828 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 2.000 | 0.000% | 15.000 | -24.000 | -1.000 | -42.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.007) | (0.116) | (0.151) | (0.293) |
| NBV per share ($) | 0.783 | -- | 0.768 | 0.411 | 0.540 | 0.543 |
| Remarks: | Real time quote last updated: 20/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 27,393 |
| %Change | -34.380% |
| EPS / (LPS) | RMB 0.020 |
| NBV Per Share (¥) | RMB 0.783 |